Mechanism of Nucleated Conformational Conversion of Aβ42

Biochemistry

Volumn 54, Issue 27, 2015, Pages 4197-4207

  Fu, Ziao ^a   Aucoin, Darryl ^a   Davis, Judianne ^a   Van Nostrand, William E ^a   Smith, Steven O ^a  

^a STONY BROOK UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ATOMIC FORCE MICROSCOPY; FOURIER TRANSFORM INFRARED SPECTROSCOPY; HYDROGEN BONDS; NEURODEGENERATIVE DISEASES; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PEPTIDES;

ALZHEIMER'S DISEASE; AMYLOID FIBRIL; CONFORMATION CONVERSION; CONFORMATIONAL CONVERSION; FIBRIL FORMATION; LOW MOLECULAR WEIGHT; SECONDARY STRUCTURES; STRUCTURAL TRANSITIONS;

OLIGOMERS;

AMYLOID BETA PROTEIN[1-42]; OLIGOMER; AMYLOID BETA PROTEIN; AMYLOID BETA-PROTEIN (1-42); PEPTIDE FRAGMENT; PROTEIN AGGREGATE;

ARTICLE; ATOMIC FORCE MICROSCOPY; BETA SHEET; CONFORMATIONAL TRANSITION; HYDROGEN BOND; INFRARED SPECTROSCOPY; MOLECULAR WEIGHT; NUCLEAR MAGNETIC RESONANCE; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN SECONDARY STRUCTURE; SOLID STATE; TEMPERATURE DEPENDENCE; ALZHEIMER DISEASE; CHEMISTRY; CIRCULAR DICHROISM; HUMAN; METABOLISM; PROTEINOSIS; TEMPERATURE; ULTRASTRUCTURE;

ALZHEIMER DISEASE; AMYLOID BETA-PEPTIDES; CIRCULAR DICHROISM; HUMANS; MICROSCOPY, ATOMIC FORCE; NUCLEAR MAGNETIC RESONANCE, BIOMOLECULAR; PEPTIDE FRAGMENTS; PROTEIN AGGREGATES; PROTEIN AGGREGATION, PATHOLOGICAL; PROTEIN STRUCTURE, SECONDARY; SPECTROSCOPY, FOURIER TRANSFORM INFRARED; TEMPERATURE;

EID: 84949641876     PISSN: 00062960     EISSN: 15204995     Source Type: Journal    
DOI: 10.1021/acs.biochem.5b00467     Document Type: Article

References (47)

1. Selkoe, D. J. (2001) Alzheimer's disease: Genes, proteins, and therapy Physiol. Rev. 81, 741-766
2. De Strooper, B., Vassar, R., and Golde, T. (2010) The secretases: Enzymes with therapeutic potential in Alzheimer disease Nat. Rev. Neurol. 6, 99-107
3. Selkoe, D. J. (2001) Clearing the brain's amyloid cobwebs Neuron 32, 177-180
4. Zlokovic, B. V., Yamada, S., Holtzman, D., Ghiso, J., and Frangione, B. (2000) Clearance of amyloid β-peptide from brain: Transport or metabolism? Nat. Med. 6, 718
5. Portelius, E., Bogdanovic, N., Gustavsson, M., Volkmann, I., Brinkmalm, G., Zetterberg, H., Winblad, B., and Blennow, K. (2010) Mass spectrometric characterization of brain amyloid β isoform signatures in familial and sporadic Alzheimer's disease Acta Neuropathol. 120, 185-193
6. Cohen, S. I. A., Linse, S., Luheshi, L. M., Hellstrand, E., White, D. A., Rajah, L., Otzen, D. E., Vendruscolo, M., Dobson, C. M., and Knowles, T. P. J. (2013) Proliferation of amyloid-β 42 aggregates occurs through a secondary nucleation mechanism Proc. Natl. Acad. Sci. U.S.A. 110, 9758-9763
7. Lee, J., Culyba, E. K., Powers, E. T., and Kelly, J. W. (2011) Amyloid-β forms fibrils by nucleated conformational conversion of oligomers Nat. Chem. Biol. 7, 602-609
8. Cheon, M., Chang, I., Mohanty, S., Luheshi, L. M., Dobson, C. M., Vendruscolo, M., and Favrin, G. (2007) Structural reorganisation and potential toxicity of oligomeric species formed during the assembly of amyloid fibrils PLoS Comput. Biol. 3, 1727-1738
9. Lambert, M. P., Barlow, A. K., Chromy, B. A., Edwards, C., Freed, R., Liosatos, M., Morgan, T. E., Rozovsky, I., Trommer, B., Viola, K. L., Wals, P., Zhang, C., Finch, C. E., Krafft, G. A., and Klein, W. L. (1998) Diffusible, nonfibrillar ligands derived from Aβ1-42 are potent central nervous system neurotoxins Proc. Natl. Acad. Sci. U.S.A. 95, 6448-6453
10. Walsh, D. M., Klyubin, I., Fadeeva, J. V., Cullen, W. K., Anwyl, R., Wolfe, M. S., Rowan, M. J., and Selkoe, D. J. (2002) Naturally secreted oligomers of amyloid β protein potently inhibit hippocampal long-term potentiation in vivo Nature 416, 535-539
11. Haass, C. and Selkoe, D. J. (2007) Soluble protein oligomers in neurodegeneration: Lessons from the Alzheimer's amyloid β-peptide Nat. Rev. Mol. Cell Biol. 8, 101-112
12. Serra-Vidal, B., Pujadas, L., Rossi, D., Soriano, E., Madurga, S., and Carulla, N. (2014) Hydrogen/deuterium exchange-protected oligomers populated during Aβ fibril formation correlate with neuronal cell death ACS Chem. Biol. 9, 2678-2685
13. Fawzi, N. L., Ying, J. F., Torchia, D. A., and Clore, G. M. (2010) Kinetics of amyloid β monomer-to-oligomer exchange by NMR relaxation J. Am. Chem. Soc. 132, 9948-9951
14. Fawzi, N. L., Ying, J., Ghirlando, R., Torchia, D. A., and Clore, G. M. (2011) Atomic-resolution dynamics on the surface of amyloid-β protofibrils probed by solution NMR Nature 480, 268-272
15. Garvey, M. and Morgado, I. (2013) Peptide concentration alters intermediate species in amyloid β fibrillation kinetics Biochem. Biophys. Res. Commun. 433, 276-280
16. Harper, J. D., Wong, S. S., Lieber, C. M., and Lansbury, P. T. (1999) Assembly of Aβ amyloid protofibrils: An in vitro model for a possible early event in Alzheimer's disease Biochemistry 38, 8972-8980
17. Moreth, J., Kroker, K. S., Schwanzar, D., Schnack, C., von Arnim, C. A. F., Hengerer, B., Rosenbrock, H., and Kussmaul, L. (2013) Globular and protofibrillar Aβ aggregates impair neurotransmission by different mechanisms Biochemistry 52, 1466-1476
18. Tay, W. M., Huang, D., Rosenberry, T. L., and Paravastu, A. K. (2013) The Alzheimer's Amyloid-β-(1-42) peptide forms off-pathway oligomers and fibrils that are distinguished structurally by intermolecular organization J. Mol. Biol. 425, 2494-2508
19. Powers, E. T. and Powers, D. L. (2008) Mechanisms of protein fibril formation: Nucleated polymerization with competing off-pathway aggregation Biophys. J. 94, 379-391
20. 1-42 oligomers to fibrils Nat. Struct. Mol. Biol. 17, 561-567
21. Hou, L. M., Shao, H. Y., Zhang, Y. B., Li, H., Menon, N. K., Neuhaus, E. B., Brewer, J. M., Byeon, I. J. L., Ray, D. G., Vitek, M. P., Iwashita, T., Makula, R. A., Przybyla, A. B., and Zagorski, M. G. (2004) Solution NMR studies of the Aβ(1-40) and Aβ(1-42) peptides establish that the Met35 oxidation state affects the mechanism of amyloid formation J. Am. Chem. Soc. 126, 1992-2005
22. Yan, Y. L. and Wang, C. Y. (2006) Aβ42 is more rigid than Aβ40 at the C terminus: Implications for Aβ aggregation and toxicity J. Mol. Biol. 364, 853-862
23. 1H dipolar-assisted rotational resonance in magic-angle spinning NMR Chem. Phys. Lett. 344, 631-637
24. Fu, Z., Aucoin, D., Ahmed, M., Ziliox, M., Van Nostrand, W. E., and Smith, S. O. (2014) Capping of Aβ42 oligomers by small molecule inhibitors Biochemistry 53, 7893-7903
25. Yamaguchi, T., Matsuzaki, K., and Hoshino, M. (2011) Transient formation of intermediate conformational states of amyloid-β peptide revealed by heteronuclear magnetic resonance spectroscopy FEBS Lett. 585, 1097-1102
26. Kim, W. and Hecht, M. H. (2006) Generic hydrophobic residues are sufficient to promote aggregation of the Alzheimer's Aβ42 peptide Proc. Natl. Acad. Sci. U.S.A. 103, 15824-15829
27. Cleary, J. P., Walsh, D. M., Hofmeister, J. J., Shankar, G. M., Kuskowski, M. A., Selkoe, D. J., and Ashe, K. H. (2005) Natural oligomers of the amyloid-protein specifically disrupt cognitive function Nat. Neurosci. 8, 79-84
28. Bernstein, S. L., Dupuis, N. F., Lazo, N. D., Wyttenbach, T., Condron, M. M., Bitan, G., Teplow, D. B., Shea, J., Ruotolo, B. T., Robinson, C. V., and Bowers, M. T. (2009) Amyloid-β protein oligomerization and the importance of tetramers and dodecamers in the aetiology of Alzheimer's disease Nat. Chem. 1, 326-331
29. Bitan, G., Kirkitadze, M. D., Lomakin, A., Vollers, S. S., Benedek, G. B., and Teplow, D. B. (2003) Amyloid β-protein (Aβ) assembly: Aβ40 and Aβ42 oligomerize through distinct pathways Proc. Natl. Acad. Sci. U.S.A. 100, 330-335
30. Garai, K. and Frieden, C. (2005) Quantitative analysis of the time course of Aβ oligomerization and subsequent growth steps using tetramethylrhodamine-labeled Aβ Proc. Natl. Acad. Sci. U.S.A. 110, 3321-3326
31. Mastrangelo, I. A., Ahmed, M., Sato, T., Liu, W., Wang, C., Hough, P., and Smith, S. O. (2006) High-resolution atomic force microscopy of soluble Aβ42 oligomers J. Mol. Biol. 358, 106-119
32. Vivekanandan, S., Brender, J. R., Lee, S. Y., and Ramamoorthy, A. (2011) A partially folded structure of amyloid-β (1-40) in an aqueous environment Biochem. Biophys. Res. Commun. 411, 312-316
33. Bolognesi, B., Kumita, J. R., Barros, T. P., Esbjorner, E. K., Luheshi, L. M., Crowther, D. C., Wilson, M. R., Dobson, C. M., Favrin, G., and Yerbury, J. J. (2010) ANS binding reveals common features of cytotoxic amyloid species ACS Chem. Biol. 5, 735-740
34. Cerf, E., Sarroukh, R., Tamamizu-Kato, S., Breydo, L., Derclaye, S., Dufrene, Y. F., Narayanaswami, V., Goormaghtigh, E., Ruysschaert, J. M., and Raussens, V. (2009) Antiparallel β-sheet: A signature structure of the oligomeric amyloid β-peptide Biochem. J. 421, 415-423
35. Sarroukh, R., Cerf, E., Derclaye, S., Dufrene, Y. F., Goormaghtigh, E., Ruysschaert, J. M., and Raussens, V. (2011) Transformation of amyloid β(1-40) oligomers into fibrils is characterized by a major change in secondary structure Cell. Mol. Life Sci. 68, 1429-1438
36. Barth, A. (2007) Infrared spectroscopy of proteins Biochim. Biophys. Acta 1767, 1073-1101
37. Paul, C., Wang, J. P., Wimley, W. C., Hochstrasser, R. M., and Axelsen, P. H. (2004) Vibrational coupling, isotopic editing, and β-sheet structure in a membrane-bound polypeptide J. Am. Chem. Soc. 126, 5843-5850
38. Petty, S. A. and Decatur, S. M. (2005) Experimental evidence for the reorganization of β-strands within aggregates of the Aβ(16-22) peptide J. Am. Chem. Soc. 127, 13488-13489
39. Masuda, Y., Uemura, S., Nakanishi, A., Ohashi, R., Takegoshi, K., Shimizu, T., Shirasawa, T., and Irie, K. (2008) Verification of the C-terminal intramolecular β-sheet in Aβ42 aggregates using solid-state NMR: Implications for potent neurotoxicity through the formation of radicals Bioorg. Med. Chem. Lett. 18, 3206-3210
40. Sato, T., Kienlen-Campard, P., Ahmed, M., Liu, W., Li, H., Elliott, J. I., Aimoto, S., Constantinescu, S. N., Octave, J. N., and Smith, S. O. (2006) Inhibitors of amyloid toxicity based on β-sheet packing of Aβ40 and Aβ42 Biochemistry 45, 5503-5516
41. Jeong, J. S., Ansaloni, A., Mezzenga, R., Lashuel, H. A., and Dietler, G. (2013) Novel mechanistic insight into the molecular basis of amyloid polymorphism and secondary nucleation during amyloid formation J. Mol. Biol. 425, 1765-1781
42. Gu, L., Liu, C., Stroud, J. C., Ngo, S., Jiang, L., and Guo, Z. (2014) Antiparallel triple-strand architecture for prefibrillar Aβ42 oligomers J. Biol. Chem. 289, 27300-27313
43. Torok, M., Milton, S., Kayed, R., Wu, P., McIntire, T., Glabe, C. G., and Langen, R. (2002) Structural and dynamic features of Alzheimer's Aβ peptide in amyloid fibrils studied by site-directed spin labeling J. Biol. Chem. 277, 40810-40815
44. Sciarretta, K. L., Gordon, D. J., Petkova, A. T., Tycko, R., and Meredith, S. C. (2005) Aβ 40-Lactam(D23/K28) models a conformation highly favorable for nucleation of amyloid Biochemistry 44, 6003-6014
45. Sandberg, A., Luheshi, L. M., Sollvander, S., de Barros, T. P., Macao, B., Knowles, T. P. J., Biverstal, H., Lendel, C., Ekholm-Petterson, F., Dubnovitsky, A., Lannfelt, L., Dobson, C. M., and Hard, T. (2010) Stabilization of neurotoxic Alzheimer amyloid-β oligomers by protein engineering Proc. Natl. Acad. Sci. U.S.A. 107, 15595-15600
46. Hard, T. (2011) Protein engineering to stabilize soluble amyloid β-protein aggregates for structural and functional studies FEBS J. 278, 3884-3892
47. O'Nuallain, B., Freir, D. B., Nicoll, A. J., Risse, E., Ferguson, N., Herron, C. E., Collinge, J., and Walsh, D. M. (2010) Amyloid β-protein dimers rapidly form stable synaptotoxic protofibrils J. Neurosci. 30, 14411-14419